Intestinal very-low-density lipoprotein secretion in the genetically obese Zucker rat.
The objectives of this study were to measure intestinal very-low-density lipoprotein (VLDL) production in obese Zucker rats and to assess an eventual effect of a high-fat diet. VLDL secretion was specifically inhibited by orotic acid, and intestinal VLDL output was measured following the Triton WR-1339 method. After a control diet, total VLDL secretion (without orotic acid) was 4.8 +/- 0.3 and 1.4 +/- 0.1 mg triacylglycerol/ml in obese and lean rats, respectively, decreasing by 30% in obese rats after fat-feeding. Intestinal VLDL production was similar in obese and lean rats fed the control diet (0.32 +/- 0.05 and 0.27 +/- 0.05 mg triacylglycerol/ml, respectively), increasing 2.5-fold after fat-feeding in both genotypes. Thus, intestine contributed 21 and 60% of total VLDL in lean but only 7 and 24% in obese rats with the control and high-fat diets, respectively. These results show that the intestine of obese Zucker rats does not contribute to their hypertriglyceridemia, suggesting that it originates solely from liver. Moreover, their intestinal VLDL production was stimulated by fat-feeding to the same extent as in lean animals.
Oussadou
L
L
Groupe de Recherches sur la Physiopathologie de la Nutrition, Institut Biomédical des Cordeliers, Paris, France.
Kalopissis
A D
AD
Francone
O L
OL
Griffaton
G
G
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002914:Chylomicrons / Q000096:biosynthesis / Q000378:metabolism; D004032:Diet; D004041:Dietary Fats; D005260:Female; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D008079:Lipoproteins, VLDL / Q000096:biosynthesis* / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009963:Orotic Acid / Q000494:pharmacology; D051381:Rats; D011924:Rats, Zucker; D012016:Reference Values
D002914:Chylomicrons; D004041:Dietary Fats; D008079:Lipoproteins, VLDL; D009963:Orotic Acid